MegaPro Biomedical , Ltd PEG Ratio

MegaPro Biomedical , Ltd (6827.TWO) currently reports a PEG ratio of 48.05. That is above the Healthcare sector average of 27.75. Use the charts on this page to explore MegaPro Biomedical , Ltd's PEG ratio history and peer comparisons.

MegaPro Biomedical , Ltd's PEG ratio of 48.05 is higher than the Healthcare sector average of 27.75. That is roughly 73.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates MegaPro Biomedical , Ltd's market price to a fundamental measure such as earnings, sales, or book value. At 48.05, 6827.TWO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 48.05, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.75. From there, open related valuation or income-statement pages for MegaPro Biomedical , Ltd, and consider following 6827.TWO for alerts when major investors trade the stock.

MegaPro Biomedical , Ltd is classified in the Healthcare sector. On PEG ratio, it currently shows 48.05 versus a sector average near 27.75. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6827.TWO with unrelated industries.